KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for NovoCure (NVCR) over the last 10 years, with Q3 2025 value amounting to -$22000.0.

  • NovoCure's Exchange Rate Effect fell 12528.74% to -$22000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $342000.0, marking a year-over-year increase of 12207.79%. This contributed to the annual value of -$174000.0 for FY2024, which is 23282.44% down from last year.
  • Per NovoCure's latest filing, its Exchange Rate Effect stood at -$22000.0 for Q3 2025, which was down 12528.74% from $265000.0 recorded in Q2 2025.
  • In the past 5 years, NovoCure's Exchange Rate Effect ranged from a high of $265000.0 in Q2 2025 and a low of -$128000.0 during Q4 2024
  • For the 5-year period, NovoCure's Exchange Rate Effect averaged around $7473.7, with its median value being -$25000.0 (2022).
  • As far as peak fluctuations go, NovoCure's Exchange Rate Effect crashed by 390000.0% in 2022, and later surged by 50535.71% in 2025.
  • NovoCure's Exchange Rate Effect (Quarter) stood at -$49000.0 in 2021, then soared by 416.33% to $155000.0 in 2022, then rose by 29.03% to $200000.0 in 2023, then crashed by 164.0% to -$128000.0 in 2024, then surged by 82.81% to -$22000.0 in 2025.
  • Its Exchange Rate Effect stands at -$22000.0 for Q3 2025, versus $265000.0 for Q2 2025 and $227000.0 for Q1 2025.